CD4+ cell counts show more improvement with early addition of interleukin-2 (IL-2) to HAART

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1248, 2000-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HAART initiation at CD4 cell counts of ≥ 200 cells/mm3 is associated with a decreased risk of anaemia, renal impairment and peripheral neuropathy

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

CD4 cell counts a plus to guide therapy initiation

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

HAART interruption feasible with CD4 monitoring

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Immunological Mechanisms of Interleukin-2 (IL-2) Treatment in HIV/AIDS Disease

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 40-45

Bentham Science Publishers

Access to resources Recommend Favorite

Routine CD4 cell counts worth it vs viral load testing during ART

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 643, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite